It has been reported that constitutively active NF-κB signaling leads to TRAIL-resistance by upregulating XIAP in multiple human cancer cells [50], and in certain tumor cell types, NF-κB is the primary cause for TRAIL resistance [10]. The gene discussed is NFKB1; the disease is neoplasm.